Natural products and their (semi-)synthetic forms in treatment of migraine: History and current status
Identifikátory výsledku
Kód výsledku v IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F60460709%3A41210%2F20%3A79183" target="_blank" >RIV/60460709:41210/20:79183 - isvavai.cz</a>
Výsledek na webu
<a href="https://pubmed.ncbi.nlm.nih.gov/30686246/" target="_blank" >https://pubmed.ncbi.nlm.nih.gov/30686246/</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.2174/0929867326666190125155947" target="_blank" >10.2174/0929867326666190125155947</a>
Alternativní jazyky
Jazyk výsledku
angličtina
Název v původním jazyce
Natural products and their (semi-)synthetic forms in treatment of migraine: History and current status
Popis výsledku v původním jazyce
BACKGROUND: Migraine may be described as a headache with moderate to extreme pain that is often accompanied by incapacitating neurological symptoms. It is estimated that 12% of the world population suffers from migraine. Although a number of drugs have been used for treatment of migraine, most of these are not effective for every patient and may have undesirable side-effects. Thus there is an enormous unmet need in current migraine therapy for discovering safer and more effective agents. METHODS: The information summarized in this review was obtained through extensive literature review and search of relevant books and articles with the use of Web of Knowledge and SciVerse Scopus databases. RESULTS: Greater understanding of the molecular mechanisms underlying the etiopathogenesis of migraine is helpful in identifying novel targets for antimigraine drugs such as cannabinoid, histamine, and melatonin receptors. In the past, natural product-derived constituents have served as an invaluable source of
Název v anglickém jazyce
Natural products and their (semi-)synthetic forms in treatment of migraine: History and current status
Popis výsledku anglicky
BACKGROUND: Migraine may be described as a headache with moderate to extreme pain that is often accompanied by incapacitating neurological symptoms. It is estimated that 12% of the world population suffers from migraine. Although a number of drugs have been used for treatment of migraine, most of these are not effective for every patient and may have undesirable side-effects. Thus there is an enormous unmet need in current migraine therapy for discovering safer and more effective agents. METHODS: The information summarized in this review was obtained through extensive literature review and search of relevant books and articles with the use of Web of Knowledge and SciVerse Scopus databases. RESULTS: Greater understanding of the molecular mechanisms underlying the etiopathogenesis of migraine is helpful in identifying novel targets for antimigraine drugs such as cannabinoid, histamine, and melatonin receptors. In the past, natural product-derived constituents have served as an invaluable source of
Klasifikace
Druh
J<sub>imp</sub> - Článek v periodiku v databázi Web of Science
CEP obor
—
OECD FORD obor
30107 - Medicinal chemistry
Návaznosti výsledku
Projekt
—
Návaznosti
S - Specificky vyzkum na vysokych skolach
Ostatní
Rok uplatnění
2020
Kód důvěrnosti údajů
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Údaje specifické pro druh výsledku
Název periodika
Current Medicinal Chemistry
ISSN
0929-8673
e-ISSN
1875-533X
Svazek periodika
27
Číslo periodika v rámci svazku
23
Stát vydavatele periodika
CZ - Česká republika
Počet stran výsledku
25
Strana od-do
3784-3808
Kód UT WoS článku
000546321000002
EID výsledku v databázi Scopus
2-s2.0-85073991246